g8 medical agency limited
g8 medical agency limited Company Information
Company Number
07300239
Next Accounts
Mar 2025
Industry
Solicitors
Directors
Shareholders
anthony baines
Group Structure
View All
Contact
Registered Address
24 clinton road, liverpool, L12 7HA
Website
www.g8medical.co.ukg8 medical agency limited Estimated Valuation
Pomanda estimates the enterprise value of G8 MEDICAL AGENCY LIMITED at £8.6m based on a Turnover of £11.4m and 0.76x industry multiple (adjusted for size and gross margin).
g8 medical agency limited Estimated Valuation
Pomanda estimates the enterprise value of G8 MEDICAL AGENCY LIMITED at £0 based on an EBITDA of £-692 and a 4.11x industry multiple (adjusted for size and gross margin).
g8 medical agency limited Estimated Valuation
Pomanda estimates the enterprise value of G8 MEDICAL AGENCY LIMITED at £6.7m based on Net Assets of £4.3m and 1.56x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
G8 Medical Agency Limited Overview
G8 Medical Agency Limited is a live company located in liverpool, L12 7HA with a Companies House number of 07300239. It operates in the solicitors sector, SIC Code 69102. Founded in June 2010, it's largest shareholder is anthony baines with a 100% stake. G8 Medical Agency Limited is a established, mid sized company, Pomanda has estimated its turnover at £11.4m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
G8 Medical Agency Limited Health Check
Pomanda's financial health check has awarded G8 Medical Agency Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
5 Weak
Size
annual sales of £11.4m, make it larger than the average company (£1.3m)
- G8 Medical Agency Limited
£1.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (6.2%)
- G8 Medical Agency Limited
6.2% - Industry AVG
Production
with a gross margin of 69.9%, this company has a comparable cost of product (69.9%)
- G8 Medical Agency Limited
69.9% - Industry AVG
Profitability
an operating margin of 0% make it less profitable than the average company (8%)
- G8 Medical Agency Limited
8% - Industry AVG
Employees
with 2 employees, this is below the industry average (15)
2 - G8 Medical Agency Limited
15 - Industry AVG
Pay Structure
on an average salary of £39.3k, the company has an equivalent pay structure (£39.3k)
- G8 Medical Agency Limited
£39.3k - Industry AVG
Efficiency
resulting in sales per employee of £5.7m, this is more efficient (£73.6k)
- G8 Medical Agency Limited
£73.6k - Industry AVG
Debtor Days
it gets paid by customers after 187 days, this is later than average (68 days)
- G8 Medical Agency Limited
68 days - Industry AVG
Creditor Days
its suppliers are paid after 81 days, this is slower than average (28 days)
- G8 Medical Agency Limited
28 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- G8 Medical Agency Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (23 weeks)
0 weeks - G8 Medical Agency Limited
23 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 26.3%, this is a lower level of debt than the average (52.8%)
26.3% - G8 Medical Agency Limited
52.8% - Industry AVG
G8 MEDICAL AGENCY LIMITED financials
G8 Medical Agency Limited's latest turnover from June 2023 is estimated at £11.4 million and the company has net assets of £4.3 million. According to their latest financial statements, G8 Medical Agency Limited has 2 employees and maintains cash reserves of £3.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||
| Other Income Or Grants | |||||||||||||
| Cost Of Sales | |||||||||||||
| Gross Profit | |||||||||||||
| Admin Expenses | |||||||||||||
| Operating Profit | |||||||||||||
| Interest Payable | |||||||||||||
| Interest Receivable | |||||||||||||
| Pre-Tax Profit | |||||||||||||
| Tax | |||||||||||||
| Profit After Tax | |||||||||||||
| Dividends Paid | |||||||||||||
| Retained Profit | |||||||||||||
| Employee Costs | |||||||||||||
| Number Of Employees | 2 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | |||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 10 | 10 | 10 | 20 | 0 | 0 | 965 | 2,094 | 3,223 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 10 | 10 | 10 | 20 | 0 | 0 | 965 | 2,094 | 3,223 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 5,831,527 | 5,755,480 | 5,662,872 | 5,324,389 | 5,663,950 | 5,596,754 | 5,775,175 | 3,102,422 | 1,510,099 | 333,270 | 656,190 | 85,736 | 7,280 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 3,159 | 35,311 | 113,163 | 135,364 | 52,303 | 23,901 | 190,656 | 898,022 | 1,300,836 | 1,498,542 | 183,251 | 60,048 | 37,707 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 15,000 | 15,000 | 15,000 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 5,834,686 | 5,790,791 | 5,776,035 | 5,459,753 | 5,716,253 | 5,635,655 | 5,980,831 | 4,015,444 | 2,810,935 | 1,831,812 | 839,441 | 145,784 | 44,987 |
| total assets | 5,834,696 | 5,790,801 | 5,776,045 | 5,459,773 | 5,716,253 | 5,635,655 | 5,981,796 | 4,017,538 | 2,814,158 | 1,831,812 | 839,441 | 145,784 | 44,987 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 764,994 | 1,491,671 | 1,569,975 | 1,330,571 | 1,608,993 | 1,627,400 | 2,683,421 | 1,565,021 | 970,211 | 90,293 | 209,997 | 125,198 | 44,612 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 770,370 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 1,535,364 | 1,491,671 | 1,569,975 | 1,330,571 | 1,608,993 | 1,627,400 | 2,683,421 | 1,565,021 | 970,211 | 90,293 | 209,997 | 125,198 | 44,612 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 153,808 | 151,526 | 247,806 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 153,808 | 151,526 | 247,806 | 0 | 0 | 0 |
| total liabilities | 1,535,364 | 1,491,671 | 1,569,975 | 1,330,571 | 1,608,993 | 1,627,400 | 2,683,421 | 1,718,829 | 1,121,737 | 338,099 | 209,997 | 125,198 | 44,612 |
| net assets | 4,299,332 | 4,299,130 | 4,206,070 | 4,129,202 | 4,107,260 | 4,008,255 | 3,298,375 | 2,298,709 | 1,692,421 | 1,493,713 | 629,444 | 20,586 | 375 |
| total shareholders funds | 4,299,332 | 4,299,130 | 4,206,070 | 4,129,202 | 4,107,260 | 4,008,255 | 3,298,375 | 2,298,709 | 1,692,421 | 1,493,713 | 629,444 | 20,586 | 375 |
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | |||||||||||||
| Depreciation | 0 | 0 | 10 | 10 | 0 | 965 | 1,129 | 1,129 | 154 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 76,047 | 92,608 | 338,483 | -339,561 | 67,196 | -178,421 | 2,672,753 | 1,592,323 | 1,176,829 | -322,920 | 570,454 | 78,456 | 7,280 |
| Creditors | -726,677 | -78,304 | 239,404 | -278,422 | -18,407 | -1,056,021 | 1,118,400 | 594,810 | 879,918 | -119,704 | 84,799 | 80,586 | 44,612 |
| Accruals and Deferred Income | 770,370 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||
| Investing Activities | |||||||||||||
| capital expenditure | |||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||
| Financing Activities | |||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | -153,808 | 2,282 | -96,280 | 247,806 | 0 | 0 | 0 |
| share issue | |||||||||||||
| interest | |||||||||||||
| cash flow from financing | |||||||||||||
| cash and cash equivalents | |||||||||||||
| cash | -32,152 | -77,852 | -22,201 | 83,061 | 28,402 | -166,755 | -707,366 | -402,814 | -197,706 | 1,315,291 | 123,203 | 22,341 | 37,707 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -32,152 | -77,852 | -22,201 | 83,061 | 28,402 | -166,755 | -707,366 | -402,814 | -197,706 | 1,315,291 | 123,203 | 22,341 | 37,707 |
g8 medical agency limited Credit Report and Business Information
G8 Medical Agency Limited Competitor Analysis
Perform a competitor analysis for g8 medical agency limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in L12 area or any other competitors across 12 key performance metrics.
g8 medical agency limited Ownership
G8 MEDICAL AGENCY LIMITED group structure
G8 Medical Agency Limited has no subsidiary companies.
Ultimate parent company
G8 MEDICAL AGENCY LIMITED
07300239
g8 medical agency limited directors
G8 Medical Agency Limited currently has 1 director, Mr Anthony Baines serving since Sep 2012.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Anthony Baines | England | 65 years | Sep 2012 | - | Director |
P&L
June 2023turnover
11.4m
+3%
operating profit
-692.4
0%
gross margin
69.9%
+2.12%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
4.3m
0%
total assets
5.8m
+0.01%
cash
3.2k
-0.91%
net assets
Total assets minus all liabilities
g8 medical agency limited company details
company number
07300239
Type
Private limited with Share Capital
industry
69102 - Solicitors
incorporation date
June 2010
age
15
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
June 2023
previous names
N/A
accountant
AQUARIUS TAX CONSULTANCY LTD
auditor
-
address
24 clinton road, liverpool, L12 7HA
Bank
-
Legal Advisor
-
g8 medical agency limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to g8 medical agency limited. Currently there are 0 open charges and 2 have been satisfied in the past.
g8 medical agency limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for G8 MEDICAL AGENCY LIMITED. This can take several minutes, an email will notify you when this has completed.
g8 medical agency limited Companies House Filings - See Documents
| date | description | view/download |
|---|
